Search

everythinglearnresearchcommunity

for

Search:↓

Somatostatin may help protect hair follicles from immune attacks.

Most patients with chronic kidney disease have skin problems, which get worse as the disease progresses, and dialysis doesn't greatly reduce these issues.

The article concludes that dermatologists should prescribe lifestyle drugs carefully and consider mental health treatments for patients with disorders like BDD.

New methods to test hair growth treatments have been developed.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Cannabinoids may help treat various skin conditions.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Hair loss improved with treatment and successful transplant.

Atopic dermatitis may have genetic causes and can be treated with pharmacologic methods, glycerin creams, and controlling Staphylococcus aureus colonization.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Advanced human skin models improve drug development and could replace animal testing.

Skin symptoms can indicate endocrine disorders and have various treatments.

Skin health and diseases are closely linked to metabolic processes.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Immune cells are essential for early hair and skin development and healing.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Immune cells affect hair growth and could lead to new hair loss treatments.